0R15 8884.0068 1.4156% 0R1E 9171.0 0.0% 0M69 None None% 0R2V 255.5 0.0% 0QYR 1619.0 0.0% 0QYP 434.5 0.0% 0RUK None None% 0RYA 1606.0 4.9673% 0RIH 195.2 1.3763% 0RIH 195.2 0.0% 0R1O 225.5 9900.0% 0R1O None None% 0QFP None None% 0M2Z 255.0 0.2457% 0VSO 33.3 -6.4738% 0R1I None None% 0QZI 604.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 246.8 2.9706%
Last update at 2024-12-26T18:50:00Z
Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a Bet
Mon 21 Oct 24, 01:30 PMVeeva Systems Inc. (VEEV): This High Growth Software Stock Is Profitable In 2024
Sun 20 Oct 24, 07:42 PMA Look Back at Vertical Software Stocks’ Q2 Earnings: Toast (NYSE:TOST) Vs The Rest Of The Pack
Fri 18 Oct 24, 08:35 AMVertical Software Stocks Q2 Teardown: Doximity (NYSE:DOCS) Vs The Rest
Fri 18 Oct 24, 08:25 AMQ2 Rundown: Veeva Systems (NYSE:VEEV) Vs Other Vertical Software Stocks
Thu 17 Oct 24, 08:41 AMVeeva to Host Virtual Investor Day on Nov. 7, 2024
Tue 15 Oct 24, 08:30 PMVertical Software Stocks Q2 Earnings: Olo (NYSE:OLO) Best of the Bunch
Mon 14 Oct 24, 08:59 AMVeeva Systems (VEEV) Advances While Market Declines: Some Information for Investors
Thu 10 Oct 24, 09:50 PM| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Income before tax | 509.10M | 512.31M | 393.99M | 313.70M | 238.64M |
| Minority interest | - | - | - | - | - |
| Net income | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Selling general administrative | 217.59M | 171.51M | 149.11M | 114.27M | 86.41M |
| Selling and marketing expenses | 348.69M | 288.06M | 235.01M | 190.33M | 148.87M |
| Gross profit | 1545.65M | 1347.10M | 1056.14M | 800.71M | 616.93M |
| Reconciled depreciation | 29.12M | 27.45M | 29.45M | 19.86M | 14.07M |
| Ebit | 459.09M | 505.50M | 377.79M | 286.22M | 222.87M |
| Ebitda | 488.21M | 532.94M | 407.25M | 314.04M | 236.94M |
| Depreciation and amortization | 29.12M | 27.45M | 29.45M | 27.82M | 14.07M |
| Non operating income net other | - | - | 16.20M | 27.48M | 15.78M |
| Operating income | 459.09M | 505.50M | 377.79M | 286.22M | 222.87M |
| Other operating expenses | 1695.97M | 1345.28M | 1087.28M | 817.86M | 639.34M |
| Interest expense | -50.00500M | 14.73M | 16.20M | 27.48M | 0.00000M |
| Tax provision | 21.39M | 84.92M | 13.99M | 12.58M | 8.81M |
| Interest income | 45.86M | 14.73M | 15.86M | 25.18M | 15.39M |
| Net interest income | 45.86M | 14.73M | 15.86M | 25.18M | 15.39M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 21.39M | 84.92M | 13.99M | 12.58M | 8.81M |
| Total revenue | 2155.06M | 1850.78M | 1465.07M | 1104.08M | 862.21M |
| Total operating expenses | 1086.56M | 841.60M | 678.35M | 514.49M | 394.06M |
| Cost of revenue | 609.40M | 503.68M | 408.93M | 303.37M | 245.28M |
| Total other income expense net | 50.01M | 6.82M | 16.20M | 27.48M | 15.78M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Net income applicable to common shares | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Total assets | 4804.30M | 3816.47M | 3046.07M | 2271.78M | 1653.77M |
| Intangible assets | 82.48M | 101.94M | 114.59M | 134.60M | 24.52M |
| Earning assets | - | - | - | - | - |
| Other current assets | 81.46M | 36.68M | 35.61M | 21.87M | 21.67M |
| Total liab | 1088.04M | 904.83M | 779.75M | 606.18M | 416.02M |
| Total stockholder equity | 3716.25M | 2911.64M | 2266.32M | 1665.59M | 1237.75M |
| Deferred long term liab | 31.82M | 33.11M | 42.07M | 2.42M | 30.87M |
| Other current liab | 84.53M | 77.70M | 63.98M | 52.85M | 28.66M |
| Common stock | 0.00200M | 0.00200M | 0.00200M | 0.00100M | 0.00100M |
| Capital stock | 0.00200M | 0.00200M | 0.00200M | 0.00100M | 0.00100M |
| Retained earnings | 2214.75M | 1727.05M | 1299.66M | 919.66M | 619.20M |
| Other liab | 31.57M | 20.44M | 12.40M | 10.20M | 14.99M |
| Good will | 439.88M | 439.88M | 436.03M | 438.53M | 95.80M |
| Other assets | 207.48M | 63.33M | 74.05M | 63.64M | 45.06M |
| Cash | 886.47M | 1138.04M | 730.50M | 476.73M | 550.97M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1006.80M | 840.78M | 715.95M | 551.17M | 401.02M |
| Current deferred revenue | 869.28M | 731.75M | 616.99M | 468.89M | 356.36M |
| Net debt | -825.48900M | -1083.45200M | -667.38600M | -421.90500M | -550.97100M |
| Short term debt | 11.31M | 10.98M | 11.72M | 10.01M | 6.89M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 60.98M | 54.59M | 63.12M | 54.83M | - |
| Other stockholder equity | 1532.63M | 1196.55M | 965.67M | 745.48M | 617.62M |
| Property plant equipment | 105.15M | 104.14M | 110.57M | 54.75M | 54.97M |
| Total current assets | 3969.31M | 3107.18M | 2310.83M | 1531.12M | 1433.41M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | 3193.90M | 2369.82M | 1715.70M | 1092.46M | 1117.42M |
| Short term investments | 2216.16M | 1238.06M | 933.12M | 610.01M | 539.19M |
| Net receivables | 785.23M | 694.40M | 611.59M | 422.51M | 321.59M |
| Long term debt | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Accounts payable | 41.68M | 20.35M | 23.25M | 19.42M | 9.11M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -31.12900M | -11.95800M | 0.99M | 0.46M | 0.93M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 0.00200M | 0.00100M | 0.00100M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | 1299.66M | 919.66M | 619.20M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 70.78M | 58.23M | 17.88M | 16.18M | 8.25M |
| Deferred long term asset charges | - | - | 42.07M | 35.59M | 36.81M |
| Non current assets total | 834.98M | 709.28M | 735.24M | 740.65M | 220.35M |
| Capital lease obligations | 60.98M | 54.59M | 63.12M | 54.83M | - |
| Long term debt total | - | - | - | 0.36M | - |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Investments | -1007.68300M | -324.15800M | -333.63400M | -64.42700M | -94.05000M |
| Change to liabilities | 161.90M | 113.15M | 148.23M | -10.43200M | 95.89M |
| Total cashflows from investing activities | -1007.68300M | -346.15200M | -333.63400M | -516.91000M | -103.86900M |
| Net borrowings | - | -0.38400M | -1.03900M | -0.98400M | -0.98400M |
| Total cash from financing activities | -19.37600M | -4.14000M | 33.82M | 10.01M | 25.91M |
| Change to operating activities | -60.66100M | -14.68100M | -32.40200M | -49.79300M | -25.48400M |
| Net income | 487.71M | 427.39M | 380.00M | 301.12M | 229.83M |
| Change in cash | -251.57500M | 409.51M | 251.91M | -72.38100M | 230.79M |
| Begin period cash flow | 1141.22M | 731.71M | 479.80M | 552.18M | 321.39M |
| End period cash flow | 889.65M | 1141.22M | 731.71M | 479.80M | 552.18M |
| Total cash from operating activities | 780.47M | 764.46M | 551.25M | 437.38M | 310.83M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 29.12M | 27.45M | 29.45M | 27.82M | 14.07M |
| Other cashflows from investing activities | - | - | -8.68300M | -449.37000M | -1.37900M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | -22.64800M | -37.98000M | -10.68000M |
| Change to account receivables | -72.17700M | -67.02000M | -174.06700M | -55.53100M | -78.99500M |
| Sale purchase of stock | - | - | 34.86M | 10.99M | 25.91M |
| Other cashflows from financing activities | -19.37600M | -3.75600M | 34.86M | 10.99M | 25.91M |
| Change to netincome | 234.21M | 262.91M | 196.76M | 109.37M | 68.36M |
| Capital expenditures | 2.49M | 2.49M | 0.57M | 4.32M | 9.82M |
| Change receivables | - | - | -174.06700M | -55.53100M | -78.99500M |
| Cash flows other operating | - | - | -32.08000M | 55.75M | -34.27700M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | 251.43M | -69.52500M | 232.87M |
| Change in working capital | 7.34M | 20.66M | -75.64600M | -18.18200M | -17.37800M |
| Stock based compensation | 351.91M | 234.64M | 185.00M | 115.91M | 76.42M |
| Other non cash items | 31.90M | 43.25M | 33.49M | 17.37M | 15.97M |
| Free cash flow | 777.98M | 761.97M | 551.81M | 433.05M | 301.01M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc Class A |
-4.88 2.24% | 212.55 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| GEHC GE HealthCare Technologies Inc. |
0.63 0.79% | 79.99 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| MTHRF M3 Inc |
- -% | 9.73 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.04 0.92% | 4.29 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
| HQY HealthEquity Inc |
1.55 1.63% | 97.23 | 123.86 | 42.37 | 6.88 | 3.38 | 7.41 | 26.13 |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and data solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
4280 Hacienda Drive, Pleasanton, CA, United States, 94588
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter P. Gassner | Founder, CEO & Director | 1965 |
| Mr. Thomas D. Schwenger | Pres & COO | 1968 |
| Mr. Brent R. Bowman | Chief Financial Officer | 1967 |
| Mr. Alan V. Mateo | Exec. VP of Global Sales | 1962 |
| Ms. Michele O'Connor | Chief Accounting Officer | 1977 |
| Mr. Pinal Patel | Chief Information Officer | NA |
| Mr. Ato Garrett | Sr. Director of Investor Relations | NA |
| Mr. Jonathan W. Faddis | Sr. VP, Gen. Counsel & Corp. Sec. | 1972 |
| Mr. Jacques Mourrain Ph.D. | VP of Quality & Compliance | NA |
| Ms. Eleni Nitsa Zuppas | Chief Marketing Officer | 1970 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...